DealsLinden to invest in healthcare RCM firm AspirionWhen the deal closes, Aspirion's previous backer Aquiline Capital Partners will remain an investor.ByIris Dorbian21 June 2022•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs